Back to Search
Start Over
[Invasive fungal infection over the last 30 years].
- Source :
-
Revista iberoamericana de micologia [Rev Iberoam Micol] 2021 Apr-Jun; Vol. 38 (2), pp. 47-51. Date of Electronic Publication: 2021 Jul 20. - Publication Year :
- 2021
-
Abstract
- Clinical mycology is in continuous development. The appearance of new clinical guidelines has made it possible to improve the approach to opportunistic fungal infections, especially in immunosuppressed patients (oncohematological and/or transplant recipients). At the same time, the development of new diagnostic tools and new antifungals with a greater spectrum of action and fewer side effects have led to faster diagnoses and treatments that are more effective. Along with these advances, there has been a change in the epidemiology of invasive fungal infection (IFI), with the appearance of new patients (e.g., COPD, liver cirrhosis, post-influenza) and new microorganisms (Candida auris, Lomentospora prolificans, mucorales), and resistant fungi (isolates of Aspergillus resistant to azoles) which the clinician must take into account when choosing the treatment of a patient with an IFI. In this paper we will briefly review the advances in recent decades and the emerging problems.<br /> (Copyright © 2021 Asociación Española de Micología. Publicado por Elsevier España, S.L.U. All rights reserved.)
Details
- Language :
- Spanish; Castilian
- ISSN :
- 2173-9188
- Volume :
- 38
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Revista iberoamericana de micologia
- Publication Type :
- Academic Journal
- Accession number :
- 34294520
- Full Text :
- https://doi.org/10.1016/j.riam.2021.03.003